Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease

Clinical Gastroenterology and Hepatology

Volumn 3, Issue 2, 2005, Pages 122-132

  Siffledeen, Jesse S ^a   Fedorak, Richard N ^a   Siminoski, Kerry ^a   Jen, Ho ^a   Vaudan, Eric ^a   Abraham, Neena ^b   Steinhart, Hillary ^c   Greenberg, Gordon ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CARBONATE; CORTICOSTEROID; ETIDRONIC ACID; VITAMIN D;

ADULT; ARTICLE; BLOATING; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG TOLERABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSPEPSIA; FEMALE; HEARTBURN; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NAUSEA; OSTEOPENIA; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; BONE DENSITY; CALCIUM; CROHN DISEASE; DENSITOMETRY, X-RAY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ETIDRONIC ACID; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PROBABILITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VITAMIN D;

EID: 13544272926     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(04)00663-9     Document Type: Article

References (59)

1. A. Habtezion, M.S. Silverberg, R. Parkes Risk factors for low bone density in Crohn's disease Inflamm Bowel Dis 8 2002 87 92
2. M. Dinca, W. Fries, G. Luisetto Evolution of osteopenia in inflammatory bowel disease Am J Gastroenterol 94 1999 1292 1297
3. J.E. Compston, D. Judd, E.O. Crawley Osteoporosis in patients with inflammatory bowel disease Gut 28 1987 410 415
4. S. Ardizzone, S. Bollani, P. Bettica Altered bone metabolism in inflammatory bowel disease there is a difference between Crohn's disease and ulcerative colitis J Intern Med 247 2000 63 70
5. R. Dressner-Pollak, F. Karmeli, R. Eliakim Femoral neck osteopenia in patients with inflammatory bowel disease Am J Gastroenterol 93 1998 1483 1490
6. J. Jahnsen, J.A. Falch, E. Aadland Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis a population based study Gut 40 1997 313 319
7. R.J. Robinson, F. Al Azzawi, S.J. Iqbal Osteoporosis and determinants of bone density in patients with Crohn's disease Dig Dis Sci 43 1998 2500 2506
8. I. Bjarnason, A. Macpherson, C. Mackintosh Reduced bone density in patients with inflammatory bowel disease Gut 40 1997 228 233
9. E.J. Schoon, A.B. Van Nunen, R.S.M.E. Wouters Osteopenia and osteoporosis in Crohn's disease prevalence in a Dutch population-based cohort Scand J Gastroenterol 35 2000 43 47
10. C. Schulte, A. Dignass, K. Mann Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease Inflamm Bowel Dis 4 1998 268 275
11. J. Siffledeen, R.N. Fedorak, K. Siminoski Bones and Crohn's analysis of risk factors associated with low bone mineral density in patients with Crohn's disease Inflamm Bowel Dis 10 2004 220 228
12. H. Vogelsang, P. Ferenci, H. Resch Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation Eur J Gastroenterol Hepatol 7 1995 609 614
13. F.A. Sylvester, N. Wyzga, J.S. Hyams Effect of Crohn's disease on bone metabolism in vitro a role for Interleukin 6 J Bone Miner Res 17 2002 695 702
14. S. Ghosh, S. Cowen, J. Hannan Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis Gastroenterology 107 1994 1031 1039
15. R.J. Robinson, S.J. Iqbal, F. Al-Azzawi Sex hormone status and bone metabolism in men with Crohn's disease Aliment Pharmacol Ther 12 1998 21 25
16. C.N. Bernstein, L.L. Seeger, J.W. Sayre Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis J Bone Miner Res 10 1995 250 256
17. M. Szathmari, B. Vasarhelyi, A. Treszl Association of dehydroepiandrosterone sulfate deficiency with bone turnover in men with inflammatory bowel disease Int J Colorectal Dis 17 2002 63 66
18. D. Clements, R.J. Motley, W.D. Evans Longitudinal study of cortical bone loss in patients with inflammatory bowel disease Scand J Gastroenterol 27 1992 1055 1060
19. R.J. Robinson, S.J. Iqbal, K. Abrams Increased bone resorption in patients with Crohn's disease Aliment Pharmacol Ther 12 1998 699 705
20. S. Bischoff, A. Herrmann, M. Goke Altered bone metabolism in inflammatory bowel disease Am J Gastroenterol 92 1997 1157 1163
21. J. Silvennoinen, L. Risteli, T. Karttunen Increased degradation of type I collagen in patients with inflammatory bowel disease Gut 38 1996 223 228
22. R. Dressner-Pollak, F. Karmeli, R. Eliakim Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease Am J Gastroenterol 95 2000 699 704
23. C.N. Bernstein, J.F. Blanchard, W. Leslie The incidence of fracture among patients with inflammatory bowel disease Ann Intern Med 133 2000 795 799
24. P. Vestergaard, L. Mosekilde Fracture risk in patients with celiac disease, Crohn's disease and ulcerative colitis a nationwide follow-up study of 16, 416 patients in Denmark Am J Epidemiol 156 2002 1 10
25. E.V.J. Loftus, C.S. Crowson, W.J. Sandborn Long term fracture risk in patients with Crohn's disease a population-based study in Olmsted County, Minnesota Gastroenterology 123 2002 468 475
26. C.N. Bernstein, L.L. Seeger, P.A. Anton A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease a pilot study Aliment Pharmacol Ther 10 1996 777 786
27. H. Vogelsang, M. Klamert, H. Resch Dietary vitamin D intake in patients with Crohn's disease Wien Klin Wochenschr 105 1995 578 581
28. C. Von Tirpitz, J. Klaus, J. Bruckel Increases of bone mineral density with sodium fluoride in patients with Crohn's disease Eur J Gastroenterol Hepatol 12 2000 19 24
29. R.J. Robinson, T. Kryswcki, L. Almond Effect of a low-impact excercise program on bone mineral density in Crohn's disease a randomized controlled trial Gastroenterology 115 1998 36 41
30. C.P. Loudon, V. Corroll, J. Butcher The effects of physical exercise on patients with Crohn's disease Am J Gastroenterol 94 1999 697 703
31. K.V. Haderslev, L. Tjellesen, H.A. Sorensen Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease Gastroenterology 119 2000 639 646
32. R.G. Russell, M.J. Rogers Bisphosphonates from the laboratory to the clinic and back again Bone 25 1999 97 106
33. H. Fleisch Bisphosphonates history and experimental basis Bone 8 1987 S23 S28
34. N.B. Watts, S.T. Harris, H.K. Genant Intermittent cyclical etidronate treatment of postmenopausal osteoporosis N Engl J Med 323 1990 73 79
35. T. Storm, G. Thamsborg, T. Steiniche Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis N Engl J Med 322 1990 1265 1271
36. F.H. Anderson, R.M. Francis, J.C. Bishop Effect of intermittent etidronate therapy on bone mineral density in men with vertebral fractures Age Ageing 26 1997 359 365
37. A. Struys, A.A. Snelder, H. Mulder Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis Am J Med 99 1995 235 242
38. P. Pitt, F. Li, P. Todd A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long term oral corticosteroid treatment Thorax 53 1998 351 356
39. P. Geusens, J. Dequeker, J. Vanhoof Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment a double blind, randomized placebo controlled study Ann Rheum Dis 57 1998 724 727
40. S.J. Skingle, D.J. Moore, A.J. Crisp Cyclical etidronate increases lumbar spine bone density in patients on long-term glucocorticosteroid therapy Int J Clin Pract 51 1997 364 367
41. B. Cortet, E. Hachulla, I. Barton Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases Rev Rhum Engl Ed 66 1999 214 219
42. J.D. Adachi, W.G. Bensen, J. Brown Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis N Engl J Med 337 1997 382 387
43. M.L.M. Montessori, W.H. Scheele, J.C. Netelenbos The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia results of three years of treatment Osteoporos Int 7 1997 52 58
44. World Health Organization Study Group Assessment of fracture risk and its application to screening for postmenopausal osteoporosis report of a WHO Study Group World Health Organ Tech Rep Ser 843 1994 1 129
45. A.C. Looker, E.S. Orwoll, C.C. Johnston Prevalence of low femoral bone density in older US adults from NHANES III J Bone Miner Res 12 1997 1761 1768
46. C. Roux, P. Oriente, R. Laan Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss Ciblos Study Group J Clin Endocrinol Metab 83 1998 1128 1133
47. E.A. Jenkins, K.E. Walker-Bone, A. Wood The prevention of corticosteroid-induced bone loss with intermittent cyclical etidronate Scand J Rheumatol 28 1997 152 156
48. F.H. Wolfhagen, H.R. Van Buuren, J.W. Den Ouden Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis a prospective, controlled pilot study J Hepatol 26 1997 325 330
49. J.D. Adachi, C. Roux, P.I. Pitt A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss J Rheumatol 27 2000 2424 2431
50. D. Hanley, G. Ioannidis, J.D. Adachi Etidronate therapy in the treatment and prevention of osteoporosis J Clin Densitom 3 2000 79 95
51. A. Cranney, G. Guyatt, N. Krolicki A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis Osteoporos Int 12 2001 140 151
52. J.P. Brown, R.G. Josse 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada CMAJ 167 2002 S1 S34
53. S.A. Bartram, R.T. Peaston, D.J. Rawlings A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease Aliment Pharmacol Ther 18 2003 1121 1127
54. V. Abitbol, J.Y. Mary, C. Roux Osteoporosis in inflammatory bowel disease effect of calcium and vitamin D with or without fluoride Aliment Pharmacol Ther 16 2002 919 927
55. R.G. Grainger, R.D. Grainger, D.J. Allison Grainger & Allison's diagnostic radiology a textbook of medical imaging 2001 Churchill Livingstone Volume 1. 4th ed. London, New York 2622
56. B.P. Lukert, L.G. Raisz Glucocorticoid-induced osteoporosis pathogenesis and management Ann Intern Med 112 1990 352 364
57. M. Fukunaga, K. Kushida, H. Kishimoto A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis a randomized controlled trial Osteoporos Int 13 2002 971 979
58. J.M. Pouilles, F. Tremollieres, C. Roux Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapy Osteoporos Int 7 1997 213 218
59. H. Valleala, J. Mandelin, L. Laasonen Effect of cyclical intermittent etidronate therapy on circulating osteoprotegerin levels in patients with rheumatoid arthritis Eur J Endocrinol 148 2003 527 530